Table 2.
Clinical Characteristics by Study Group (N = 97)
| Characteristic | Overall (N = 97) |
Control (N = 60) |
Experimental (N = 37) |
|
|---|---|---|---|---|
| N (%) | N (%) | N (%) | p | |
| Cancer relapse or recurrence | ||||
| No | 28 (28.9) | 16 (26.7) | 12 (32.4) | 0.543 |
| Yes | 69 (71.1) | 44 (73.3) | 25 (67.6) | |
| Secondary cancer | ||||
| No | 95 (97.9) | 58 (96.7) | 37 (100.0) | 0.262 |
| Yes | 2 (2.1) | 2 (3.3) | 0 (0.0) | |
| Surgery to remove tumor | ||||
| No | 56 (57.7) | 36 (60.0) | 20 (54.1) | 0.565 |
| Yes | 41 (42.3) | 24 (40.0) | 17 (45.9) | |
| Chemotherapy | ||||
| No | 5 (5.2) | 2 (3.3) | 3 (8.1) | 0.302 |
| Yes | 92 (94.8) | 58 (96.7) | 34 (91.9) | |
| Radiation | ||||
| No | 28 (28.9) | 18 (30.0) | 10 (27.0) | 0.754 |
| Yes | 69 (71.1) | 42 (70.0) | 27 (73.0) | |
| Bone marrow transplant | N = 96 | N = 36 | ||
| No | 83 (86.5) | 50 (83.3) | 33 (91.7) | 0.248 |
| Yes | 13 (13.5) | 10 (16.7) | 3 (8.3) | |
| Phase I study | ||||
| No | 63 (64.9) | 37 (61.7) | 26 (70.3) | 0.395 |
| Yes | 14 (14.4) | 8 (13.3) | 6 (16.2) | |
| Unsure | 20 (20.6) | 15 (25.0) | 5 (13.5) | |
| Notified cancer is terminal | ||||
| No | 90 (92.8) | 55 (91.7) | 35 (94.6) | 0.588 |
| Yes | 7 (7.2) | 5 (8.3) | 2 (5.4) | |
| DNR order in place | ||||
| No | 95 (97.9) | 60 (100.0) | 35 (94.6) | 0.069 |
| Yes | 2 (2.1) | 0 (0.0) | 2 (5.4) | |
| Hospice | ||||
| No | 94 (96.9) | 58 (96.7) | 36 (97.3) | 0.692 |
| Yes | 2 (2.1) | 1 (1.7) | 1 (2.7) | |
| Unknown | 1 (1.0) | 1 (1.7) | 0 (0.0) | |
| Palliative care | ||||
| No | 85 (87.6) | 51 (85.0) | 34 (91.9) | 0.195 |
| Yes | 7 (7.2) | 4 (6.7) | 3 (8.1) | |
| Unknown | 5 (5.2) | 5 (8.3) | 0 (0.0) | |
DNR, do-not-resuscitate order.